Nizatidine is a histamine H2-receptor antagonist that inhibits stomach acid production, and commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). It was developed by Eli Lilly and is marketed under the trade names Tazac and Axid.
3 edits since May 19, 2008. Last edited Jul 25, 2008 by Thijs!bot (119).
This Compound Monograph is licensed under the GNU Free Documentation License and uses material from the Wikipedia article Nizatidine. See this site's terms for details.